Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.

Respiratory syncytial virus (RSV) pneumonia in marrow transplant recipients is associated with significant mortality. Ribavirin is a nucleoside analog with activity against RSV and in its aerosolized formulation is the only drug approved for treatment of RSV pneumonia in the United States. The clini...

Повний опис

Бібліографічні деталі

Опубліковано в::	Antimicrob Agents Chemother
Автори:	Lewinsohn, D M, Bowden, R A, Mattson, D, Crawford, S W
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology (ASM) 1996
Предмети:	Research Article
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163574/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8913463/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.11.2555
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!